Regulation of hepatitis C virus replication and gene expression by the MAPK-ERK pathway

Rongjuan Pei1, Xiaoyong Zhang, Song Xu

  • 1Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.

Virologica Sinica
|September 25, 2012
PubMed

Insights

The mitogen-activated protein kinase-extracellular signal-regulated kinase (MAPK-ERK) pathway significantly impacts Hepatitis C virus (HCV) replication and protein expression. Inhibiting this pathway enhances viral RNA load and protein levels, influencing interferon signaling.

Area of Science:

  • Virology
  • Cellular Biology
  • Molecular Biology

Background:

  • The mitogen-activated protein kinases-extracellular signal-regulated kinases (MAPK-ERK) pathway regulates crucial cellular processes, including the cell cycle.
  • Hepatitis C virus (HCV) replication is a complex process influenced by host cell machinery.

Purpose of the Study:

  • To investigate the role of the MAPK-ERK pathway in regulating HCV replication and protein expression.
  • To explore the interplay between the MAPK-ERK pathway, cell cycle, and interferon-alpha (IFN-α) signaling in HCV infection.

Main Methods:

  • Utilized a Huh7 cell line (Con1) harboring an HCV replicon.
  • Administered epithelial growth factor (EGF) to stimulate ERK activation and U0126 (a MAPK-ERK inhibitor) to block the pathway.
  • Assessed HCV RNA load, NS5A protein levels, and HCV internal ribosome entry site (IRES)-directed translation.
  • Investigated the effects of cyclin-dependent kinase (CDK) inhibitors (roscovitine) and cell cycle modulators.
  • Examined the impact of IFN-α and its interaction with MAPK-ERK and CDK inhibitors on HCV replication and interferon-stimulated genes.

Main Results:

  • EGF stimulation decreased HCV RNA load, while U0126 treatment increased HCV RNA and NS5A protein levels.
  • MAPK-ERK pathway inhibition enhanced HCV IRES-mediated translation and reporter replicon activity.
  • CDK inhibition mimicked the effects of U0126 on HCV replication.
  • Cell cycle modulation altered HCV RNA levels.
  • IFN-α inhibited HCV replication, an effect partially reversed by MAPK-ERK and CDK inhibitors.
  • MAPK-ERK inhibitors modulated the expression of interferon-stimulated genes.

Conclusions:

  • The MAPK-ERK pathway is a significant regulator of HCV gene expression and replication.
  • CDKs downstream of ERK may also play a role in modulating HCV replication.
  • The MAPK-ERK pathway influences the response to IFN-α treatment in HCV-infected cells.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...